Cargando…

Artificial Intelligence Based on Blood Biomarkers Including CTCs Predicts Outcomes in Epithelial Ovarian Cancer: A Prospective Study

OBJECTIVE: We aimed to develop an ovarian cancer-specific predictive framework for clinical use platinum-sensitivity and prognosis using machine learning methods based on multiple biomarkers, including circulating tumor cells (CTCs). PATIENTS AND METHODS: We enrolled 156 epithelial ovarian cancer (E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Jun, Yang, Jiani, Jin, Yue, Cheng, Shanshan, Huang, Shan, Zhang, Nan, Wang, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140950/ https://www.ncbi.nlm.nih.gov/pubmed/34040391 http://dx.doi.org/10.2147/OTT.S307546

Ejemplares similares

Artificial intelligence-based preoperative prediction system for diagnosis and prognosis in epithelial ovarian cancer: A multicenter study
por: Wu, Meixuan, et al.
Publicado: (2022)

Development and validation for prognostic nomogram of epithelial ovarian cancer recurrence based on circulating tumor cells and epithelial–mesenchymal transition
por: Yang, Jiani, et al.
Publicado: (2021)

ERBB signaling in CTCs of ovarian cancer and glioblastoma
por: Geethadevi, Anjali, et al.
Publicado: (2017)

Clinical significance for combined coagulation indexes in epithelial ovarian cancer prognosis
por: Yang, Jiani, et al.
Publicado: (2021)

Potential Use of CTCs as Biomarkers in Renal Cancer Patients
por: Bialek, Joanna, et al.
Publicado: (2022)

Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer
por: Cheng, Shanshan, et al.
Publicado: (2020)

Apoptotic circulating tumor cells (CTCs) in the peripheral blood of metastatic colorectal cancer patients are associated with liver metastasis but not CTCs
por: Allen, Joshua E., et al.
Publicado: (2013)

Evaluation of α-tubulin, detyrosinated α-tubulin, and vimentin in CTCs: identification of the interaction between CTCs and blood cells through cytoskeletal elements
por: Kallergi, G., et al.
Publicado: (2018)

Application of Ovarian Cancer Organoids in Precision Medicine: Key Challenges and Current Opportunities
por: Yang, Jiani, et al.
Publicado: (2021)

The Combination of Plasma Fibrinogen Concentration and Neutrophil Lymphocyte Ratio (F-NLR) as a Prognostic Factor of Epithelial Ovarian Cancer
por: Yang, Jiani, et al.
Publicado: (2020)

Combined detection and subclass characteristics analysis of CTCs and CTECs by SE-iFISH in ovarian cancer
por: Cheng, Hongyan, et al.
Publicado: (2021)

Measuring kinetics and metastatic propensity of CTCs by blood exchange between mice
por: Hamza, Bashar, et al.
Publicado: (2021)

Review and Prospect: Artificial Intelligence in Advanced Medical Imaging
por: Wang, Shanshan, et al.
Publicado: (2021)

Circulating tumor cells (CTCs) and hTERT gene expression in CTCs for radiotherapy effect with lung cancer
por: Xu, Ying, et al.
Publicado: (2023)

Sequential Method for Analysis of CTCs and Exosomes from the Same Sample of Patient Blood
por: Zhu, Jianhui, et al.
Publicado: (2022)

Liquid Biopsy in Lung Cancer: Clinical Applications of Circulating Biomarkers (CTCs and ctDNA)
por: Lim, Minji, et al.
Publicado: (2018)

CTCs 2020: Great Expectations or Unreasonable Dreams
por: Rossi, Elisabetta, et al.
Publicado: (2019)

Explainable Artificial Intelligence for Prediction of Complete Surgical Cytoreduction in Advanced-Stage Epithelial Ovarian Cancer
por: Laios, Alexandros, et al.
Publicado: (2022)

The Use of Artificial Intelligence for Complete Cytoreduction Prediction in Epithelial Ovarian Cancer: A Narrative Review
por: Parpinel, Giulia, et al.
Publicado: (2023)

Design of a Hybrid Inertial and Magnetophoretic Microfluidic Device for CTCs Separation from Blood
por: Nasiri, Rohollah, et al.
Publicado: (2021)

Exploration of Potential miRNA Biomarkers and Prediction for Ovarian Cancer Using Artificial Intelligence
por: Hamidi, Farzaneh, et al.
Publicado: (2021)

Construction and validation of a novel ferroptosis-related signature for evaluating prognosis and immune microenvironment in ovarian cancer
por: Yang, Jiani, et al.
Publicado: (2023)

Factors Predicting Surgical Effort Using Explainable Artificial Intelligence in Advanced Stage Epithelial Ovarian Cancer
por: Laios, Alexandros, et al.
Publicado: (2022)

The Trend of CEACAM3 Blood Expression as Number Index of the CTCs in the Colorectal Cancer Perioperative Course
por: Taddei, A., et al.
Publicado: (2015)

Low Expression of Circular RNA hsa_circ_0078607 Predicts Poor Prognosis in High-Grade Serous Ovarian Cancer
por: Zhang, Nan, et al.
Publicado: (2021)

EMT, CTCs and CSCs in tumor relapse and drug-resistance
por: Mitra, Abhisek, et al.
Publicado: (2015)

CTCs Expression Profiling for Advanced Breast Cancer Monitoring
por: Pereira-Veiga, Thais, et al.
Publicado: (2019)

Combinatorial Power of cfDNA, CTCs and EVs in Oncology
por: Keup, Corinna, et al.
Publicado: (2022)

Ex vivo expansion of circulating tumour cells (CTCs)
por: Mohamed, Bashir M., et al.
Publicado: (2023)

Are Circulating Tumor Cells (CTCs) Ready for Clinical Use in Breast Cancer? An Overview of Completed and Ongoing Trials Using CTCs for Clinical Treatment Decisions
por: Schochter, Fabienne, et al.
Publicado: (2019)

Application Status and Prospects of Artificial Intelligence in Peptic Ulcers
por: Zhao, Peng-yue, et al.
Publicado: (2022)

Artificial intelligence and cholangiocarcinoma: Updates and prospects
por: Haghbin, Hossein, et al.
Publicado: (2022)

The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer
por: Kapeleris, Joanna, et al.
Publicado: (2018)

Pure CTCs, advanced WGS, and precise personalized combination therapies
por: Peters, Brock A., et al.
Publicado: (2017)

Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases
por: Mamdouhi, Tania, et al.
Publicado: (2019)

Molecular characterization of breast cancer CTCs associated with brain metastasis
por: Boral, Debasish, et al.
Publicado: (2017)

Circulating Tumor Cells (CTCs): A Unique Model of Cancer Metastases and Non-invasive Biomarkers of Therapeutic Response
por: Liu, Jialing, et al.
Publicado: (2021)

Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer
por: Mego, Michal, et al.
Publicado: (2016)

Detection of circulating tumor cells (CTCs) in cerebrospinal fluid of a patient with HER2-overexpressing gastric cancer and single cell analysis of intra-patient heterogeneity of CTCs
por: Cho, Jang Ho, et al.
Publicado: (2019)

The prospective of Artificial Intelligence in COVID-19 Pandemic
por: Swayamsiddha, Swati, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hhh9l1k13njuce7re4agp0j79j